Abstract
Treatment of extensively drug-resistant tuberculosis (XDR-TB) is a challenge. We describe a young child with pulmonary XDR-TB who did not respond to an aggressive multidrug-resistant TB treatment regimen, but was cured with linezolid in combination with other reserve antituberculous drugs. No serious adverse events were observed during 19 months of treatment for XDR-TB.
MeSH terms
-
Acetamides / administration & dosage*
-
Acetamides / adverse effects
-
Antitubercular Agents / administration & dosage*
-
Drug Administration Schedule
-
Drug Resistance, Multiple, Bacterial*
-
Extensively Drug-Resistant Tuberculosis / drug therapy*
-
Extensively Drug-Resistant Tuberculosis / microbiology
-
Female
-
Humans
-
Infant
-
Linezolid
-
Oxazolidinones / administration & dosage*
-
Oxazolidinones / adverse effects
-
Tuberculosis, Pulmonary / drug therapy*
-
Tuberculosis, Pulmonary / microbiology
Substances
-
Acetamides
-
Antitubercular Agents
-
Oxazolidinones
-
Linezolid